YAPALI, S. Et Al. 2022. Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis. AASLD-TASL digital Hepatology Connect .

YAPALI, S., GÖKCAN, H., DURAK, S., MELEKOĞLU ELLİK, Z., VATANSEVER, S., ADANIR, H., ... GÜNDÜZ, F. F.(2022). Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis . AASLD-TASL digital Hepatology Connect

YAPALI, SUNA Et Al. "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis," AASLD-TASL digital Hepatology Connect, 2022

YAPALI, SUNA Et Al. "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis." AASLD-TASL digital Hepatology Connect , 2022

YAPALI, S. Et Al. (2022) . "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis." AASLD-TASL digital Hepatology Connect .

@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis}, congress name={AASLD-TASL digital Hepatology Connect}, city={}, country={}, year={2022}}